Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  616 results for ""OMALIZUMAB""

Your Filters

Subject : sinusitis
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The use of biologics in patients suffering from chronic rhinosinusitis with nasal polyps - a 4-year real life observation.

  • Authors : Frankenberger H; Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Ludwig Maximilian University of Munich, Munich, Germany. .; Wiebringhaus R

Subjects: Sinusitis*/Sinusitis*/Sinusitis*/drug therapy ; Sinusitis*/Sinusitis*/Sinusitis*/complications ; Nasal Polyps*/Nasal Polyps*/Nasal Polyps*/drug therapy

  • Source: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Publisher: Springer International Country of Publication: Germany NLM ID: 9002937 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Omalizumab improves sleep and health status for patients with chronic rhinosinusitis with nasal polyps: An analysis of randomized clinical trials.

  • Authors : Meltzer EO; Division of Allergy and Immunology, University of California, San Diego, La Jolla, California, USA.; Mullol J

Subjects: Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use ; Nasal Polyps*/Nasal Polyps*/Nasal Polyps*/drug therapy ; Sinusitis*/Sinusitis*/Sinusitis*/drug therapy

  • Source: International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2024 Jul; Vol. 14 (7), pp. 1163-1172. Date of Electronic Publication: 2024 Jan 10.Publisher: Published for ARS-AAOA by Wiley-Blackwell Country of Publication: United States NLM ID: 101550261 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Postmarketing Analysis of Eosinophilic Adverse Reactions in the use of Biologic Therapies for Type 2 Inflammatory Conditions.

  • Authors : Gershnabel Milk D; Divisions of Rhinology, Endoscopic Skull Base Surgery, and Allergy, Department of Otolaryngology - Head Neck Surgery, Eastern Virginia Medical School, Norfolk, VA, USA.; Division of Rhinology, Department of Otolaryngology - Head Neck Surgery, Meir Medical Center, Kfar Saba, Israel.

Subjects: Sinusitis*/Sinusitis*/Sinusitis*/drug therapy ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use

  • Source: American journal of rhinology & allergy [Am J Rhinol Allergy] 2025 Jan; Vol. 39 (1), pp. 38-48. Date of Electronic Publication: 2024 Sep 15.Publisher: SAGE Publications Country of Publication: United States NLM ID: 101490775 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The Efficacy of Omalizumab in Patients with Chronic Rhinosinusitis with Nasal Polyps and Comorbid Severe Allergic Asthma.

  • Authors : Atayik E; Department of Allergy and Clinical Immunology, Konya City Hospital, University of Health Sciences, Konya, Turkey. .; Aytekin G

Subjects: Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use ; Nasal Polyps*/Nasal Polyps*/Nasal Polyps*/drug therapy ; Nasal Polyps*/Nasal Polyps*/Nasal Polyps*/complications

  • Source: Iranian journal of allergy, asthma, and immunology [Iran J Allergy Asthma Immunol] 2024 May 27; Vol. 23 (3), pp. 245-256. Date of Electronic Publication: 2024 May 27.Publisher: Tehran University of Medical Sciences Country of Publication: Iran NLM ID: 101146178 Publication Model: Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Omalizumab Treatment in Uncontrolled Asthma and CRSwNP Patients, with Previous Endoscopic Sinus Surgery, to Improve Quality of Life and Endoscopic Outcomes: a Two-Year Real-Life Study.

Subjects: Asthma*/Asthma*/Asthma*/complications ; Asthma*/Asthma*/Asthma*/drug therapy ; Nasal Polyps*/Nasal Polyps*/Nasal Polyps*/complications

  • Source: Current allergy and asthma reports [Curr Allergy Asthma Rep] 2023 Oct; Vol. 23 (10), pp. 555-566. Date of Electronic Publication: 2023 Aug 30.Publisher: Current Science Inc Country of Publication: United States NLM ID: 101096440 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Chronic Rhinosinusitis with Nasal Polyps: Targeting IgE with Anti-IgE Omalizumab Therapy.

  • Authors : Kariyawasam HH; Specialist Allergy and Clinical Immunology, Royal National ENT Hospital, University College London Hospitals NHS Foundation Trust, London, UK.; Department of Rhinology, Royal National ENT Hospital, University College London Hospitals NHS Foundation Trust, London, UK.

Subjects: Anti-Allergic Agents/Anti-Allergic Agents/Anti-Allergic Agents/*pharmacology ; Nasal Polyps/Nasal Polyps/Nasal Polyps/*drug therapy ; Omalizumab/Omalizumab/Omalizumab/*pharmacology

  • Source: Drug design, development and therapy [Drug Des Devel Ther] 2020 Dec 10; Vol. 14, pp. 5483-5494. Date of Electronic Publication: 2020 Dec 10 (Print Publication: 2020).Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.

  • Authors : Gevaert P; Upper Airway Research Laboratory, Department of Otorhinolaryngology, Ghent University Hospital, Ghent, Belgium.; Omachi TA

Subjects: Anti-Allergic Agents/Anti-Allergic Agents/Anti-Allergic Agents/*therapeutic use ; Nasal Polyps/Nasal Polyps/Nasal Polyps/*drug therapy ; Omalizumab/Omalizumab/Omalizumab/*therapeutic use

  • Source: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2020 Sep; Vol. 146 (3), pp. 595-605. Date of Electronic Publication: 2020 Jun 07.Publisher: Mosby Country of Publication: United States NLM ID: 1275002 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6825

Record details

Read More Add to Saved list
×
Academic Journal

Omalizumab in patients with NSAIDs-exacerbated respiratory disease.

  • Authors : Forster-Ruhrmann U; Department of Oto-Rhino-Laryngology, Campus Virchow-Klinikum, Charite - Universitatsmedizin Berlin, Berlin, Germany; Department of Oto-Rhino-Laryngology, Campus Mitte, Charite - Universitatsmedizin Berlin, Berlin, Germany.

Subjects: Anti-Inflammatory Agents, Non-Steroidal*/Anti-Inflammatory Agents, Non-Steroidal*/Anti-Inflammatory Agents, Non-Steroidal*/therapeutic use ; Nasal Polyps*/Nasal Polyps*/Nasal Polyps*/complications ; Nasal Polyps*/Nasal Polyps*/Nasal Polyps*/drug therapy

  • Source: Rhinology [Rhinology] 2020 Jun 01; Vol. 58 (3), pp. 226-232.Publisher: International Rhinologic Society Country of Publication: Netherlands NLM ID: 0347242 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[The efficacy of omalizumab in the treatment of chronic rhinosinusitis with nasal polyps: a discussion of 2 refractory cases].

  • Authors : Jandus P; Service d'allergologie et immunologie clinique, HUG, 1211 Genève 14.; Harr T

Subjects: Nasal Polyps/Nasal Polyps/Nasal Polyps/*complications ; Omalizumab/Omalizumab/Omalizumab/*therapeutic use ; Rhinitis/Rhinitis/Rhinitis/*complications

  • Source: Revue medicale suisse [Rev Med Suisse] 2019 Oct 02; Vol. 15 (665), pp. 1748-1751.Publisher: Médecine et Hygiène Country of Publication: Switzerland NLM ID: 101219148 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Omalizumab for chronic rhinosinusitis.

  • Authors : Brañes R; Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Proyecto Epistemonikos, Santiago, Chile.

Subjects: Omalizumab/Omalizumab/Omalizumab/*therapeutic use ; Rhinitis/Rhinitis/Rhinitis/*drug therapy ; Sinusitis/Sinusitis/Sinusitis/*drug therapy

  • Source: Medwave [Medwave] 2018 Nov 23; Vol. 18 (7), pp. e7347. Date of Electronic Publication: 2018 Nov 23.Publisher: Medwave Estudios Limitada Country of Publication: Chile NLM ID: 101581949 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  616 results for ""OMALIZUMAB""